Updated 3-Year Findings of ECHELON-1 Trial Presented for Classical Hodgkin Lymphoma

Hodgkin Lymphoma: ECHELON-1 Update from ASCO 2022Подробнее

Five year update of ECHELON-1 for classical Hodgkin lymphomaПодробнее

Dr. Straus on the 3-Year Results of the ECHELON-1 Study in Hodgkin LymphomaПодробнее

Andrea Gallamini, EHA 2019 – Three-year Update of the ECHELON-1 StudyПодробнее

Echelon-1 study 3 year update: Frontline brentuximab vedotin with chemotherapy for stage 3/4 cla...Подробнее

Updated ECHELON-1 Findings Demonstrate Toxicities of Brentuximab Vedotin Combo in Hodgkin LymphomaПодробнее

Updated ECHELON-1 Findings Demonstrate Potential Toxicities of Brentuximab Vedotin Combo in cHLПодробнее